Why Can't We Eradicate Equine Herpesvirus?
Eradication of infectious diseases is a great goal, but it's rarely practical. The best known (and perhaps only) example of infectious disease eradication is the elimination of smallpox. So, why is it so hard to do?
The following general criteria need to be in place to eradicate a disease:
- It must have a clearly defined host range and that range is ideally only one species. A disease that can affect multiple species is very hard to control.
- It must predictably cause disease in individuals that are infected.
- There must be no long-term carriage state. Once a person/animal gets over the illness, he/she/it must get rid of the infection completely in a defined and predictable period of time.
- A highly effective vaccine should be available.
- There must be a commitment to put in lots of time, money and effort everywhere the disease exists.
This isn't the case with most diseases, and equine herpesvirus (EHV) has many characteristics that make eradication impossible:
- Unpredictable disease: EHV infection doesn't always cause signs of disease. When it does cause disease the signs can be quite variable and difficult to easily differentiate from other infections.
- Longterm carriage: This is the biggest problem with herpesviruses. EHV is able to survive in a latent (dormant) state in the body after infection. It can lie dormant for a long period of time, but infected animals can always start shedding the virus again. A large percentage of horses are carrying EHV in their bodies and there's no way to get rid of it.
- Vaccine: Vaccines are available but they are by no means 100% effective at preventing infection.
- Time, effort, money and cooperation are terms that are not commonly associated with disease control in horses. Getting everyone to follow a standard recommendation (if one were able to control disease) would be difficult to impossible. The entire horse-owning population would not be willing to spend the money for broad control measures, and there's no real impetus for governments to do so. Even getting people to agree to follow basic vaccination and infection control recommendations is difficult. If there is any negative impact on use of horses, ease of management or any other minor inconvenience, 100% compliance with any recommendation becomes impossible to obtain.
We have to live with EHV. It will always be a risk to horses. Good infection control measures and vaccination of certain groups (e.g. pregnant mares) can help control the impact of the virus.

.jpg)
Dr. Bob Wright of the
"A two-day horse show is different than an eight-day fair exhibition.'" Two days is lots of time to transmit infectious diseases.
While it's a little early in the foaling season, it never hurts to think about vaccination plans for foals. Vaccination is an important part of the disease prevention program - but it's only one part... general
The outbreak occurred at a racetrack in Zagreb. Not surprisingly, an H3N8 strain was responsible. Investigation of the cases determined that vaccine status had no influence on disease - both vaccinated and unvaccinated horses became equally sick. The vaccine used in Croatia at that time contained three influenza strains, including two different H3N8 strains, but the strains that were used were from 1963 and 1979. When they compared the strain that caused the outbreak and the vaccine strains, there were multiple genetic differences, which is not surprising given influenza's capacity to evolve over time. There were far fewer differences with the more recent strains used in vaccines in most other countries.
The latest version of the DEFRA/AHT/BEVA Equine Quarterly Disease Report has been released. This is a joint venture of three British organizations, and often contains some interesting infectious disease information. This edition contains brief information about diagnoses of selected diseases such as
Influenza vaccination is an important preventive strategy in people, and much effort is made to vaccinate as many people as possible with effective vaccines. Every year, the
The December 2008 newsletter from the University of Guelph's 
